| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Foot Diseases | 15 | 2022 | 143 | 4.890 |
Why?
|
| Foot | 17 | 2017 | 527 | 4.790 |
Why?
|
| Hallux Valgus | 11 | 2022 | 65 | 3.540 |
Why?
|
| Bone Density | 68 | 2023 | 3468 | 3.090 |
Why?
|
| Rheumatic Diseases | 10 | 2021 | 592 | 2.980 |
Why?
|
| Hip Fractures | 23 | 2021 | 955 | 2.500 |
Why?
|
| Accidental Falls | 19 | 2021 | 1062 | 2.450 |
Why?
|
| Rheumatology | 7 | 2023 | 576 | 2.280 |
Why?
|
| Dietary Proteins | 11 | 2017 | 963 | 2.270 |
Why?
|
| Pain | 22 | 2024 | 4987 | 2.260 |
Why?
|
| Osteoporosis | 43 | 2022 | 1579 | 2.240 |
Why?
|
| Shoes | 5 | 2016 | 97 | 1.800 |
Why?
|
| Osteoarthritis | 25 | 2023 | 1036 | 1.680 |
Why?
|
| Pronation | 5 | 2017 | 51 | 1.650 |
Why?
|
| Periodicals as Topic | 5 | 2021 | 1431 | 1.350 |
Why?
|
| Hallux Rigidus | 2 | 2022 | 13 | 1.340 |
Why?
|
| Diet | 24 | 2023 | 7937 | 1.320 |
Why?
|
| Osteoporotic Fractures | 8 | 2023 | 401 | 1.320 |
Why?
|
| Dairy Products | 6 | 2022 | 498 | 1.270 |
Why?
|
| Mobility Limitation | 4 | 2015 | 409 | 1.200 |
Why?
|
| Knee Joint | 21 | 2019 | 1680 | 1.160 |
Why?
|
| Postural Balance | 9 | 2015 | 620 | 1.020 |
Why?
|
| Pain Measurement | 8 | 2022 | 3420 | 0.980 |
Why?
|
| Hammer Toe Syndrome | 3 | 2013 | 12 | 0.960 |
Why?
|
| Milk | 5 | 2022 | 450 | 0.940 |
Why?
|
| Flatfoot | 4 | 2013 | 55 | 0.920 |
Why?
|
| Ankle Joint | 5 | 2022 | 411 | 0.910 |
Why?
|
| Posture | 5 | 2017 | 958 | 0.900 |
Why?
|
| Aging | 20 | 2017 | 8663 | 0.880 |
Why?
|
| Osteoporosis, Postmenopausal | 7 | 2018 | 386 | 0.850 |
Why?
|
| Toilet Facilities | 1 | 2021 | 26 | 0.830 |
Why?
|
| Arthritis | 3 | 2019 | 659 | 0.790 |
Why?
|
| Aged | 159 | 2023 | 163284 | 0.770 |
Why?
|
| Walking | 5 | 2016 | 1180 | 0.770 |
Why?
|
| Bone and Bones | 12 | 2022 | 2576 | 0.760 |
Why?
|
| Aged, 80 and over | 100 | 2022 | 57776 | 0.750 |
Why?
|
| Absorptiometry, Photon | 30 | 2022 | 1725 | 0.730 |
Why?
|
| Biomedical Research | 3 | 2021 | 3309 | 0.720 |
Why?
|
| Vitamin B Complex | 3 | 2021 | 288 | 0.690 |
Why?
|
| Independent Living | 5 | 2022 | 568 | 0.670 |
Why?
|
| Fractures, Bone | 10 | 2018 | 1947 | 0.670 |
Why?
|
| Geriatric Assessment | 6 | 2015 | 1372 | 0.660 |
Why?
|
| Muscle Strength | 3 | 2020 | 592 | 0.660 |
Why?
|
| Quadriceps Muscle | 2 | 2017 | 144 | 0.650 |
Why?
|
| Cross-Sectional Studies | 42 | 2023 | 25041 | 0.640 |
Why?
|
| Muscle, Skeletal | 8 | 2018 | 4925 | 0.640 |
Why?
|
| Ankle | 8 | 2024 | 327 | 0.610 |
Why?
|
| Supination | 2 | 2014 | 68 | 0.580 |
Why?
|
| Body Fluid Compartments | 1 | 2017 | 52 | 0.580 |
Why?
|
| Dietary Supplements | 8 | 2017 | 3296 | 0.580 |
Why?
|
| Massachusetts | 29 | 2017 | 8662 | 0.580 |
Why?
|
| Osteoarthritis, Knee | 7 | 2018 | 1222 | 0.580 |
Why?
|
| Calcium, Dietary | 4 | 2015 | 526 | 0.580 |
Why?
|
| Gait | 5 | 2015 | 793 | 0.580 |
Why?
|
| Feeding Behavior | 8 | 2018 | 3188 | 0.570 |
Why?
|
| Musculoskeletal Diseases | 3 | 2023 | 581 | 0.560 |
Why?
|
| Male | 169 | 2023 | 350118 | 0.560 |
Why?
|
| Editorial Policies | 1 | 2021 | 451 | 0.560 |
Why?
|
| Female | 181 | 2024 | 380200 | 0.560 |
Why?
|
| Vitamin D | 9 | 2020 | 3224 | 0.550 |
Why?
|
| Homocysteine | 3 | 2008 | 647 | 0.530 |
Why?
|
| Middle Aged | 116 | 2023 | 213388 | 0.530 |
Why?
|
| Humans | 218 | 2024 | 744376 | 0.520 |
Why?
|
| Foot Deformities | 2 | 2013 | 36 | 0.510 |
Why?
|
| Risk Factors | 68 | 2023 | 72295 | 0.500 |
Why?
|
| Vibration | 4 | 2015 | 326 | 0.500 |
Why?
|
| Arthralgia | 3 | 2013 | 456 | 0.490 |
Why?
|
| Muscles | 2 | 2023 | 1614 | 0.460 |
Why?
|
| Environment | 3 | 2014 | 1123 | 0.450 |
Why?
|
| Cohort Studies | 56 | 2023 | 40558 | 0.450 |
Why?
|
| Fasciitis, Plantar | 1 | 2013 | 36 | 0.450 |
Why?
|
| Micronutrients | 2 | 2015 | 375 | 0.440 |
Why?
|
| Yogurt | 1 | 2013 | 72 | 0.440 |
Why?
|
| Body Mass Index | 22 | 2023 | 12720 | 0.440 |
Why?
|
| Femur Neck | 9 | 2018 | 309 | 0.420 |
Why?
|
| Sensation Disorders | 1 | 2012 | 156 | 0.410 |
Why?
|
| Pressure | 5 | 2015 | 1203 | 0.390 |
Why?
|
| Joint Instability | 4 | 2019 | 792 | 0.390 |
Why?
|
| Acids | 1 | 2011 | 127 | 0.370 |
Why?
|
| Foot Joints | 3 | 2019 | 36 | 0.360 |
Why?
|
| Nutritional Status | 3 | 2011 | 1609 | 0.360 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2013 | 546 | 0.360 |
Why?
|
| Carotenoids | 5 | 2022 | 624 | 0.350 |
Why?
|
| Cartilage Diseases | 1 | 2011 | 160 | 0.350 |
Why?
|
| Adiposity | 3 | 2023 | 1806 | 0.340 |
Why?
|
| Longitudinal Studies | 28 | 2023 | 13988 | 0.340 |
Why?
|
| Vitamin K 1 | 2 | 2007 | 48 | 0.340 |
Why?
|
| Low Back Pain | 2 | 2019 | 956 | 0.340 |
Why?
|
| Lumbar Vertebrae | 12 | 2019 | 1848 | 0.340 |
Why?
|
| Lower Extremity | 1 | 2017 | 1158 | 0.340 |
Why?
|
| Protective Agents | 1 | 2010 | 156 | 0.340 |
Why?
|
| Osteoarthritis, Spine | 2 | 2019 | 6 | 0.340 |
Why?
|
| Disease Management | 1 | 2020 | 2460 | 0.330 |
Why?
|
| Societies, Medical | 2 | 2019 | 3743 | 0.330 |
Why?
|
| Obesity | 8 | 2023 | 12745 | 0.330 |
Why?
|
| Odds Ratio | 15 | 2022 | 9849 | 0.330 |
Why?
|
| Intelligence | 2 | 2011 | 920 | 0.330 |
Why?
|
| Weight-Bearing | 4 | 2015 | 515 | 0.320 |
Why?
|
| Fatigue | 1 | 2016 | 1531 | 0.320 |
Why?
|
| Disability Evaluation | 3 | 2014 | 1827 | 0.310 |
Why?
|
| Range of Motion, Articular | 2 | 2017 | 1578 | 0.310 |
Why?
|
| Calcaneus | 3 | 2006 | 138 | 0.300 |
Why?
|
| Body Height | 2 | 2012 | 1578 | 0.300 |
Why?
|
| Dyslipidemias | 1 | 2014 | 849 | 0.290 |
Why?
|
| Reminder Systems | 1 | 2010 | 371 | 0.290 |
Why?
|
| Diet Surveys | 5 | 2022 | 1173 | 0.290 |
Why?
|
| Mental Health | 1 | 2021 | 3014 | 0.280 |
Why?
|
| Residence Characteristics | 2 | 2014 | 2050 | 0.280 |
Why?
|
| Osteoarthritis, Hip | 3 | 2018 | 412 | 0.280 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2023 | 3712 | 0.270 |
Why?
|
| Functional Laterality | 2 | 2013 | 2290 | 0.270 |
Why?
|
| Spine | 10 | 2019 | 1144 | 0.270 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2014 | 4424 | 0.270 |
Why?
|
| Eating | 5 | 2022 | 1536 | 0.270 |
Why?
|
| Hand Strength | 3 | 2021 | 448 | 0.270 |
Why?
|
| Population Surveillance | 3 | 2013 | 2616 | 0.260 |
Why?
|
| Sex Factors | 17 | 2021 | 10400 | 0.260 |
Why?
|
| Publishing | 1 | 2013 | 833 | 0.260 |
Why?
|
| Equipment and Supplies | 3 | 2013 | 281 | 0.260 |
Why?
|
| Osteocalcin | 1 | 2006 | 273 | 0.260 |
Why?
|
| Adult | 58 | 2023 | 214056 | 0.260 |
Why?
|
| Femur | 12 | 2015 | 1297 | 0.250 |
Why?
|
| Health Surveys | 3 | 2011 | 4036 | 0.250 |
Why?
|
| Logistic Models | 11 | 2022 | 13409 | 0.250 |
Why?
|
| Intra-Abdominal Fat | 2 | 2023 | 591 | 0.250 |
Why?
|
| Antirheumatic Agents | 1 | 2014 | 1338 | 0.250 |
Why?
|
| Motor Activity | 5 | 2020 | 2715 | 0.240 |
Why?
|
| Prospective Studies | 34 | 2023 | 53291 | 0.240 |
Why?
|
| Cartilage, Articular | 2 | 2011 | 1095 | 0.240 |
Why?
|
| Depression | 3 | 2023 | 7766 | 0.240 |
Why?
|
| Radius | 4 | 2021 | 422 | 0.240 |
Why?
|
| Hospitals, University | 1 | 2006 | 570 | 0.240 |
Why?
|
| Follow-Up Studies | 30 | 2023 | 39052 | 0.230 |
Why?
|
| Patient Compliance | 4 | 2013 | 2685 | 0.230 |
Why?
|
| Mental Recall | 1 | 2010 | 1206 | 0.230 |
Why?
|
| Raynaud Disease | 1 | 2024 | 75 | 0.230 |
Why?
|
| Urban Health | 1 | 2006 | 547 | 0.230 |
Why?
|
| Flavonols | 1 | 2023 | 83 | 0.220 |
Why?
|
| Bone Resorption | 4 | 2013 | 723 | 0.220 |
Why?
|
| Nutrition Assessment | 3 | 2015 | 723 | 0.220 |
Why?
|
| Quercetin | 1 | 2023 | 93 | 0.220 |
Why?
|
| Juglans | 1 | 2023 | 43 | 0.210 |
Why?
|
| Exercise | 2 | 2019 | 5615 | 0.210 |
Why?
|
| Wounds and Injuries | 2 | 2014 | 2400 | 0.210 |
Why?
|
| Prevalence | 15 | 2020 | 15221 | 0.210 |
Why?
|
| Educational Status | 6 | 2009 | 2540 | 0.210 |
Why?
|
| North Carolina | 6 | 2021 | 315 | 0.200 |
Why?
|
| Methylmalonic Acid | 1 | 2021 | 49 | 0.200 |
Why?
|
| Ascorbic Acid | 4 | 2022 | 651 | 0.200 |
Why?
|
| History, 21st Century | 2 | 2021 | 1534 | 0.200 |
Why?
|
| Boston | 12 | 2014 | 9312 | 0.200 |
Why?
|
| Forecasting | 2 | 2021 | 2951 | 0.200 |
Why?
|
| Calcium Citrate | 1 | 2020 | 6 | 0.190 |
Why?
|
| Interleukin-6 | 3 | 2022 | 3203 | 0.190 |
Why?
|
| Linear Models | 10 | 2021 | 5952 | 0.190 |
Why?
|
| Parathyroid Hormone | 1 | 2007 | 1800 | 0.190 |
Why?
|
| Mental Disorders | 1 | 2021 | 6600 | 0.190 |
Why?
|
| Orthotic Devices | 2 | 2012 | 128 | 0.190 |
Why?
|
| Tuberculosis | 2 | 2006 | 1912 | 0.190 |
Why?
|
| Muscle Fatigue | 1 | 2020 | 82 | 0.180 |
Why?
|
| Scleroderma, Systemic | 1 | 2024 | 323 | 0.180 |
Why?
|
| Hip Joint | 4 | 2019 | 1002 | 0.170 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3508 | 0.170 |
Why?
|
| Estrogen Replacement Therapy | 8 | 2000 | 1203 | 0.170 |
Why?
|
| Social Isolation | 1 | 2021 | 365 | 0.170 |
Why?
|
| Tibia | 3 | 2021 | 1077 | 0.160 |
Why?
|
| Chloride Channels | 1 | 2020 | 227 | 0.160 |
Why?
|
| Body Composition | 6 | 2018 | 2402 | 0.160 |
Why?
|
| Radiography | 19 | 2014 | 7023 | 0.160 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2018 | 68 | 0.160 |
Why?
|
| Self Report | 3 | 2015 | 3557 | 0.160 |
Why?
|
| Calcium | 7 | 2020 | 5755 | 0.150 |
Why?
|
| Risk Assessment | 8 | 2023 | 23336 | 0.150 |
Why?
|
| Energy Intake | 3 | 2015 | 2148 | 0.150 |
Why?
|
| Caffeine | 3 | 2018 | 699 | 0.150 |
Why?
|
| Leg | 2 | 2015 | 1116 | 0.150 |
Why?
|
| Cholecalciferol | 2 | 2020 | 535 | 0.150 |
Why?
|
| Multivariate Analysis | 9 | 2018 | 12244 | 0.150 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2018 | 215 | 0.140 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2018 | 417 | 0.140 |
Why?
|
| Incidence | 18 | 2020 | 20950 | 0.140 |
Why?
|
| Genetic Linkage | 4 | 2009 | 2421 | 0.140 |
Why?
|
| Models, Biological | 3 | 2012 | 9584 | 0.140 |
Why?
|
| Body Weight | 5 | 2018 | 4671 | 0.140 |
Why?
|
| Diffusion of Innovation | 1 | 2021 | 725 | 0.140 |
Why?
|
| Life Style | 4 | 2018 | 3835 | 0.140 |
Why?
|
| Activities of Daily Living | 5 | 2013 | 2418 | 0.130 |
Why?
|
| Diet, Mediterranean | 1 | 2022 | 700 | 0.130 |
Why?
|
| Aorta, Abdominal | 5 | 2002 | 646 | 0.130 |
Why?
|
| Age Factors | 16 | 2020 | 18373 | 0.130 |
Why?
|
| Access to Information | 1 | 2019 | 320 | 0.130 |
Why?
|
| Calcinosis | 5 | 2007 | 1499 | 0.130 |
Why?
|
| Sex Characteristics | 9 | 2016 | 2585 | 0.130 |
Why?
|
| Recurrence | 4 | 2017 | 8340 | 0.130 |
Why?
|
| Obesity, Abdominal | 2 | 2023 | 361 | 0.120 |
Why?
|
| Postmenopause | 4 | 2020 | 2460 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2020 | 15520 | 0.120 |
Why?
|
| Psychotropic Drugs | 2 | 2013 | 894 | 0.120 |
Why?
|
| Parkinson Disease | 2 | 2018 | 2775 | 0.120 |
Why?
|
| Recreation | 1 | 2014 | 115 | 0.120 |
Why?
|
| Quality of Life | 3 | 2022 | 12803 | 0.120 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2015 | 370 | 0.110 |
Why?
|
| Meat | 2 | 2015 | 592 | 0.110 |
Why?
|
| Risk | 7 | 2018 | 9688 | 0.110 |
Why?
|
| Chickens | 1 | 2015 | 865 | 0.110 |
Why?
|
| Fear | 1 | 2021 | 1440 | 0.110 |
Why?
|
| Arteriosclerosis | 4 | 2002 | 1092 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 896 | 0.110 |
Why?
|
| Fishes | 1 | 2015 | 569 | 0.100 |
Why?
|
| Seafood | 1 | 2015 | 384 | 0.100 |
Why?
|
| Adipose Tissue | 4 | 2023 | 3280 | 0.100 |
Why?
|
| Podiatry | 1 | 2011 | 22 | 0.100 |
Why?
|
| Tarsal Bones | 1 | 2012 | 65 | 0.100 |
Why?
|
| Frail Elderly | 2 | 2011 | 693 | 0.100 |
Why?
|
| Vitamin D Deficiency | 2 | 2020 | 1343 | 0.100 |
Why?
|
| Extremities | 1 | 2017 | 866 | 0.100 |
Why?
|
| Molecular Epidemiology | 2 | 2006 | 468 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2021 | 1860 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2023 | 20130 | 0.090 |
Why?
|
| Accidents, Home | 1 | 2010 | 75 | 0.090 |
Why?
|
| Acceleration | 1 | 2011 | 181 | 0.090 |
Why?
|
| England | 1 | 2011 | 522 | 0.090 |
Why?
|
| Proportional Hazards Models | 7 | 2020 | 12356 | 0.090 |
Why?
|
| Physical Exertion | 1 | 1993 | 695 | 0.090 |
Why?
|
| Vitamin B 12 | 2 | 2021 | 527 | 0.090 |
Why?
|
| Adaptation, Psychological | 1 | 2021 | 2575 | 0.090 |
Why?
|
| Quantitative Trait Loci | 3 | 2020 | 2019 | 0.090 |
Why?
|
| Sex Distribution | 6 | 2004 | 2297 | 0.090 |
Why?
|
| Knee | 1 | 2011 | 274 | 0.090 |
Why?
|
| Abdominal Fat | 1 | 2011 | 223 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2000 | 1832 | 0.090 |
Why?
|
| United States | 10 | 2023 | 69869 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 2011 | 317 | 0.090 |
Why?
|
| Vitamin K | 2 | 2003 | 295 | 0.090 |
Why?
|
| Alcoholic Beverages | 2 | 2009 | 265 | 0.090 |
Why?
|
| Body Size | 1 | 2012 | 461 | 0.080 |
Why?
|
| Alendronate | 1 | 2010 | 171 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2020 | 658 | 0.080 |
Why?
|
| Bone Density Conservation Agents | 2 | 2020 | 772 | 0.080 |
Why?
|
| Connective Tissue | 1 | 2011 | 420 | 0.080 |
Why?
|
| Time Factors | 13 | 2020 | 40077 | 0.080 |
Why?
|
| Atrophy | 1 | 2013 | 1584 | 0.080 |
Why?
|
| Military Personnel | 1 | 2017 | 1133 | 0.080 |
Why?
|
| Nonlinear Dynamics | 1 | 2011 | 502 | 0.080 |
Why?
|
| Silicon | 1 | 2009 | 145 | 0.080 |
Why?
|
| Inflammation | 3 | 2023 | 10636 | 0.080 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 840 | 0.080 |
Why?
|
| Epidemiologic Methods | 2 | 2010 | 1364 | 0.080 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2009 | 544 | 0.080 |
Why?
|
| C-Reactive Protein | 2 | 2022 | 3778 | 0.080 |
Why?
|
| Bone Malalignment | 1 | 2007 | 38 | 0.080 |
Why?
|
| Calibration | 1 | 2010 | 816 | 0.070 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 19905 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2002 | 2015 | 0.070 |
Why?
|
| Women's Health | 1 | 1996 | 2034 | 0.070 |
Why?
|
| Sarcopenia | 1 | 2012 | 368 | 0.070 |
Why?
|
| Nursing Homes | 2 | 2013 | 1036 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2021 | 6542 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2887 | 0.070 |
Why?
|
| Self Care | 1 | 2012 | 786 | 0.070 |
Why?
|
| Telephone | 1 | 2010 | 617 | 0.070 |
Why?
|
| Smoking | 11 | 2006 | 8987 | 0.070 |
Why?
|
| Animals | 10 | 2022 | 168770 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 1996 | 2716 | 0.070 |
Why?
|
| Aortic Diseases | 2 | 2002 | 743 | 0.070 |
Why?
|
| Health Behavior | 2 | 2014 | 2635 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2007 | 1157 | 0.070 |
Why?
|
| Appointments and Schedules | 1 | 2010 | 417 | 0.070 |
Why?
|
| Prognosis | 5 | 2016 | 29060 | 0.070 |
Why?
|
| Estradiol | 2 | 2006 | 2020 | 0.070 |
Why?
|
| Ireland | 1 | 2006 | 161 | 0.070 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 719 | 0.070 |
Why?
|
| Hand | 3 | 2001 | 884 | 0.070 |
Why?
|
| Young Adult | 6 | 2021 | 56434 | 0.070 |
Why?
|
| Habits | 1 | 2006 | 139 | 0.070 |
Why?
|
| Age Distribution | 6 | 2003 | 2902 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 1686 | 0.070 |
Why?
|
| Social Class | 1 | 2014 | 1997 | 0.060 |
Why?
|
| Carbonated Beverages | 1 | 2006 | 214 | 0.060 |
Why?
|
| Fibrosarcoma | 1 | 2007 | 348 | 0.060 |
Why?
|
| Regression Analysis | 7 | 2007 | 6459 | 0.060 |
Why?
|
| Qualitative Research | 2 | 2024 | 2682 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2013 | 2740 | 0.060 |
Why?
|
| Psychometrics | 1 | 2014 | 3002 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5749 | 0.060 |
Why?
|
| Fruit | 4 | 2008 | 1142 | 0.060 |
Why?
|
| Vegetables | 4 | 2008 | 1182 | 0.060 |
Why?
|
| Alcohol Drinking | 4 | 2009 | 3966 | 0.060 |
Why?
|
| Medicare | 1 | 2021 | 6566 | 0.060 |
Why?
|
| Hyperhomocysteinemia | 1 | 2004 | 124 | 0.060 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2004 | 116 | 0.060 |
Why?
|
| Health Status | 1 | 1996 | 4033 | 0.060 |
Why?
|
| Joint Diseases | 1 | 2007 | 479 | 0.060 |
Why?
|
| Anthocyanins | 1 | 2023 | 79 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2002 | 26 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 27 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2020 | 10943 | 0.050 |
Why?
|
| Research | 1 | 2011 | 1999 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 676 | 0.050 |
Why?
|
| Orthopedics | 1 | 2011 | 904 | 0.050 |
Why?
|
| Patient Dropouts | 1 | 2004 | 421 | 0.050 |
Why?
|
| Thoracic Vertebrae | 1 | 2006 | 608 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2023 | 369 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2007 | 1125 | 0.050 |
Why?
|
| Puerto Rico | 2 | 2013 | 356 | 0.050 |
Why?
|
| Chronic Disease | 1 | 1996 | 9145 | 0.050 |
Why?
|
| Motivation | 1 | 2011 | 1971 | 0.050 |
Why?
|
| Genotype | 3 | 2021 | 12952 | 0.050 |
Why?
|
| Acid-Base Equilibrium | 1 | 2001 | 185 | 0.050 |
Why?
|
| Demography | 1 | 2006 | 1656 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2004 | 940 | 0.050 |
Why?
|
| Nuts | 1 | 2023 | 257 | 0.050 |
Why?
|
| Vitamin K Deficiency | 1 | 2000 | 24 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2004 | 575 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2003 | 661 | 0.050 |
Why?
|
| Vitamin B 6 | 1 | 2021 | 237 | 0.050 |
Why?
|
| Flavonoids | 1 | 2023 | 443 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2023 | 779 | 0.040 |
Why?
|
| Lumbosacral Region | 2 | 2018 | 310 | 0.040 |
Why?
|
| Spinal Fractures | 1 | 2006 | 696 | 0.040 |
Why?
|
| Magnesium | 2 | 2001 | 813 | 0.040 |
Why?
|
| Weight Loss | 1 | 2011 | 2625 | 0.040 |
Why?
|
| Genome-Wide Association Study | 3 | 2020 | 12262 | 0.040 |
Why?
|
| Least-Squares Analysis | 2 | 2016 | 379 | 0.040 |
Why?
|
| Menopause | 2 | 2006 | 1626 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2000 | 462 | 0.040 |
Why?
|
| Public Opinion | 1 | 2023 | 477 | 0.040 |
Why?
|
| Retrospective Studies | 8 | 2015 | 77459 | 0.040 |
Why?
|
| Periosteum | 1 | 1999 | 138 | 0.040 |
Why?
|
| Ossification, Heterotopic | 1 | 2001 | 239 | 0.040 |
Why?
|
| Receptors, Calcitriol | 1 | 2000 | 348 | 0.040 |
Why?
|
| Diphosphonates | 1 | 2003 | 623 | 0.040 |
Why?
|
| Catheters, Indwelling | 1 | 2000 | 426 | 0.040 |
Why?
|
| Phenotype | 3 | 2022 | 16367 | 0.040 |
Why?
|
| Testosterone | 2 | 2006 | 2419 | 0.040 |
Why?
|
| Vitamins | 2 | 2020 | 1623 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 17445 | 0.040 |
Why?
|
| Ultrasonography | 3 | 2006 | 5984 | 0.040 |
Why?
|
| Confidence Intervals | 3 | 2016 | 2971 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 1856 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1403 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7281 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 3020 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 2949 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2020 | 780 | 0.030 |
Why?
|
| Genome, Human | 3 | 2004 | 4420 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 15535 | 0.030 |
Why?
|
| Tooth Loss | 1 | 1998 | 197 | 0.030 |
Why?
|
| Equipment Design | 1 | 2004 | 3582 | 0.030 |
Why?
|
| Carboxylesterase | 1 | 2015 | 31 | 0.030 |
Why?
|
| Potassium, Dietary | 2 | 2009 | 96 | 0.030 |
Why?
|
| Tooth | 1 | 1997 | 207 | 0.030 |
Why?
|
| Microsatellite Repeats | 3 | 2003 | 802 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 2000 | 514 | 0.030 |
Why?
|
| Office Visits | 1 | 2000 | 598 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 7914 | 0.030 |
Why?
|
| Femoral Fractures | 1 | 1999 | 376 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2023 | 63115 | 0.030 |
Why?
|
| Procollagen | 1 | 2015 | 185 | 0.030 |
Why?
|
| Cholesterol | 1 | 2004 | 2919 | 0.030 |
Why?
|
| Potassium | 1 | 1999 | 1336 | 0.030 |
Why?
|
| Folic Acid | 1 | 2021 | 1300 | 0.030 |
Why?
|
| Hypogonadism | 1 | 2000 | 799 | 0.030 |
Why?
|
| Sarcoma | 1 | 2006 | 1897 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 4740 | 0.030 |
Why?
|
| Bone Transplantation | 1 | 1999 | 907 | 0.030 |
Why?
|
| Adolescent | 5 | 2021 | 85784 | 0.030 |
Why?
|
| Bacteremia | 1 | 2000 | 963 | 0.030 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2000 | 810 | 0.030 |
Why?
|
| Bunion, Tailor's | 1 | 2012 | 2 | 0.030 |
Why?
|
| Physicians | 1 | 2011 | 4567 | 0.030 |
Why?
|
| Connecticut | 1 | 1993 | 366 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2012 | 2539 | 0.030 |
Why?
|
| Metacarpus | 2 | 2004 | 35 | 0.030 |
Why?
|
| Electric Impedance | 1 | 1997 | 729 | 0.030 |
Why?
|
| Lod Score | 2 | 2004 | 614 | 0.030 |
Why?
|
| Predictive Value of Tests | 5 | 2011 | 15078 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2001 | 1161 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 592 | 0.030 |
Why?
|
| Toe Joint | 1 | 2011 | 19 | 0.030 |
Why?
|
| Research Design | 2 | 2023 | 5986 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 3395 | 0.030 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2000 | 912 | 0.030 |
Why?
|
| Vitamin E | 1 | 1996 | 869 | 0.030 |
Why?
|
| Knee Injuries | 2 | 1996 | 490 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2000 | 1771 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2018 | 3587 | 0.020 |
Why?
|
| Placebos | 1 | 2015 | 1676 | 0.020 |
Why?
|
| Data Collection | 1 | 2000 | 3339 | 0.020 |
Why?
|
| Refusal to Participate | 1 | 2010 | 24 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2019 | 21747 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12025 | 0.020 |
Why?
|
| Morbidity | 2 | 2008 | 1768 | 0.020 |
Why?
|
| Organ Size | 2 | 2009 | 2251 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2004 | 6077 | 0.020 |
Why?
|
| Beer | 1 | 2009 | 127 | 0.020 |
Why?
|
| Estrogens | 2 | 1996 | 1566 | 0.020 |
Why?
|
| American Heart Association | 1 | 2013 | 1057 | 0.020 |
Why?
|
| Rehabilitation Centers | 1 | 2010 | 254 | 0.020 |
Why?
|
| Wine | 1 | 2009 | 165 | 0.020 |
Why?
|
| Observer Variation | 2 | 2010 | 2593 | 0.020 |
Why?
|
| Disabled Persons | 1 | 1998 | 1212 | 0.020 |
Why?
|
| Accidents | 1 | 1989 | 164 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 1993 | 1745 | 0.020 |
Why?
|
| Antioxidants | 1 | 1996 | 1659 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 1222 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15159 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2023 | 8551 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8319 | 0.020 |
Why?
|
| Analysis of Variance | 4 | 2004 | 6366 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2008 | 505 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2009 | 340 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1405 | 0.020 |
Why?
|
| Automobiles | 1 | 1987 | 116 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 970 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 41005 | 0.020 |
Why?
|
| Lead Poisoning | 1 | 1987 | 301 | 0.020 |
Why?
|
| Premenopause | 1 | 2009 | 1033 | 0.020 |
Why?
|
| Osteoclasts | 1 | 2008 | 729 | 0.020 |
Why?
|
| Pedigree | 2 | 2002 | 4642 | 0.020 |
Why?
|
| Metronidazole | 2 | 1982 | 217 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2005 | 321 | 0.020 |
Why?
|
| Algorithms | 3 | 2013 | 13882 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 8038 | 0.010 |
Why?
|
| Models, Statistical | 2 | 2011 | 5101 | 0.010 |
Why?
|
| Hip | 1 | 2004 | 257 | 0.010 |
Why?
|
| Spermatocidal Agents | 1 | 1982 | 15 | 0.010 |
Why?
|
| Peptides | 1 | 2015 | 4410 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 2086 | 0.010 |
Why?
|
| Bread | 1 | 2002 | 23 | 0.010 |
Why?
|
| Infant Mortality | 1 | 1988 | 754 | 0.010 |
Why?
|
| Candy | 1 | 2002 | 37 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 11366 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5096 | 0.010 |
Why?
|
| Seasons | 1 | 2008 | 1493 | 0.010 |
Why?
|
| Ethanol | 1 | 2009 | 1342 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1989 | 1058 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2003 | 915 | 0.010 |
Why?
|
| Child | 2 | 2021 | 77708 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 1420 | 0.010 |
Why?
|
| Time | 1 | 2002 | 542 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2000 | 331 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2003 | 733 | 0.010 |
Why?
|
| London | 1 | 2000 | 233 | 0.010 |
Why?
|
| Acute Disease | 1 | 2010 | 7147 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 2000 | 277 | 0.010 |
Why?
|
| Homosexuality | 1 | 2000 | 262 | 0.010 |
Why?
|
| Equipment Contamination | 1 | 2000 | 185 | 0.010 |
Why?
|
| Diaphyses | 1 | 1999 | 65 | 0.010 |
Why?
|
| Models, Genetic | 2 | 2000 | 3493 | 0.010 |
Why?
|
| Blood Specimen Collection | 1 | 2000 | 246 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 1987 | 1469 | 0.010 |
Why?
|
| External Fixators | 1 | 1999 | 94 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 2383 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2010 | 2063 | 0.010 |
Why?
|
| Heart Failure | 1 | 2002 | 10895 | 0.010 |
Why?
|
| Gonorrhea | 1 | 1982 | 335 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1998 | 919 | 0.010 |
Why?
|
| Bicuspid | 1 | 1998 | 74 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2000 | 869 | 0.010 |
Why?
|
| Cuspid | 1 | 1998 | 58 | 0.010 |
Why?
|
| Africa | 1 | 2000 | 672 | 0.010 |
Why?
|
| Bone Nails | 1 | 1999 | 219 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1801 | 0.010 |
Why?
|
| Homes for the Aged | 1 | 2000 | 260 | 0.010 |
Why?
|
| Arthrography | 1 | 1998 | 149 | 0.010 |
Why?
|
| Comorbidity | 1 | 2012 | 10388 | 0.010 |
Why?
|
| Vagina | 1 | 1982 | 825 | 0.010 |
Why?
|
| Jaw, Edentulous | 1 | 1998 | 93 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2003 | 1375 | 0.010 |
Why?
|
| Molar | 1 | 1998 | 152 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 2002 | 905 | 0.010 |
Why?
|
| Disease Progression | 3 | 2001 | 13285 | 0.010 |
Why?
|
| Incisor | 1 | 1998 | 179 | 0.010 |
Why?
|
| Hydroxycholecalciferols | 1 | 1996 | 44 | 0.010 |
Why?
|
| Fracture Fixation | 1 | 1999 | 354 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 4216 | 0.010 |
Why?
|
| DNA | 2 | 2000 | 7294 | 0.010 |
Why?
|
| DNA Primers | 1 | 2000 | 2891 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2000 | 668 | 0.010 |
Why?
|
| Bone Regeneration | 1 | 1999 | 427 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1998 | 641 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2000 | 14723 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1998 | 1005 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 9957 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1681 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 4933 | 0.010 |
Why?
|
| beta Carotene | 1 | 1996 | 527 | 0.010 |
Why?
|
| Alveolar Bone Loss | 1 | 1998 | 383 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2000 | 1438 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1997 | 705 | 0.010 |
Why?
|
| Patella | 1 | 1996 | 320 | 0.010 |
Why?
|
| Dogs | 1 | 1999 | 3912 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1999 | 2124 | 0.010 |
Why?
|
| Fractures, Spontaneous | 1 | 1995 | 230 | 0.010 |
Why?
|
| Physical Fitness | 1 | 1998 | 732 | 0.010 |
Why?
|
| HIV Infections | 1 | 2000 | 16715 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 8949 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 6171 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 16692 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2002 | 3444 | 0.010 |
Why?
|
| Public Health | 1 | 2002 | 2602 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18034 | 0.000 |
Why?
|
| Computer Simulation | 1 | 2000 | 6194 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 2000 | 3680 | 0.000 |
Why?
|
| Occupational Health | 1 | 1991 | 808 | 0.000 |
Why?
|
| Air Pollutants, Occupational | 1 | 1987 | 408 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1992 | 3914 | 0.000 |
Why?
|
| Infant, Low Birth Weight | 1 | 1988 | 850 | 0.000 |
Why?
|
| Cataract | 1 | 1989 | 834 | 0.000 |
Why?
|
| Sterilization, Reproductive | 1 | 1982 | 21 | 0.000 |
Why?
|
| Contraceptive Devices, Female | 1 | 1982 | 43 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 13104 | 0.000 |
Why?
|
| Mutation | 1 | 2007 | 29786 | 0.000 |
Why?
|
| Washington | 1 | 1982 | 313 | 0.000 |
Why?
|
| Lead | 1 | 1987 | 852 | 0.000 |
Why?
|
| Software | 1 | 1995 | 4442 | 0.000 |
Why?
|
| Marriage | 1 | 1982 | 339 | 0.000 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1982 | 238 | 0.000 |
Why?
|
| Contraceptives, Oral | 1 | 1982 | 564 | 0.000 |
Why?
|
| Mice | 1 | 2007 | 81202 | 0.000 |
Why?
|
| Neoplasms | 1 | 1982 | 21693 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 1987 | 4232 | 0.000 |
Why?
|
| Sexual Behavior | 1 | 1982 | 2055 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1988 | 25628 | 0.000 |
Why?
|
| Infant | 1 | 1988 | 35134 | 0.000 |
Why?
|